Illinois General Assembly - Full Text of HB2036
Illinois General Assembly

Previous General Assemblies

Full Text of HB2036  94th General Assembly

HB2036 94TH GENERAL ASSEMBLY


 


 
94TH GENERAL ASSEMBLY
State of Illinois
2005 and 2006
HB2036

 

Introduced 2/14/2005, by Rep. Michael J. Madigan - Barbara Flynn Currie - Kevin Joyce

 

SYNOPSIS AS INTRODUCED:
 
320 ILCS 25/3.15   from Ch. 67 1/2, par. 403.15

    Amends the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act. Makes a technical change in a Section concerning prescription drugs covered under the Act.


LRB094 02653 DRJ 32654 b

 

 

A BILL FOR

 

HB2036 LRB094 02653 DRJ 32654 b

1     AN ACT concerning aging.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Senior Citizens and Disabled Persons
5 Property Tax Relief and Pharmaceutical Assistance Act is
6 amended by changing Section 3.15 as follows:
 
7     (320 ILCS 25/3.15)  (from Ch. 67 1/2, par. 403.15)
8     Sec. 3.15. "Covered prescription drug" means (1) any
9 cardiovascular agent or drug; (2) any insulin or other
10 prescription drug used in the the treatment of diabetes,
11 including syringe and needles used to administer the insulin;
12 (3) any prescription drug used in the treatment of arthritis,
13 (4) beginning on January 1, 2001, any prescription drug used in
14 the treatment of cancer, (5) beginning on January 1, 2001, any
15 prescription drug used in the treatment of Alzheimer's disease,
16 (6) beginning on January 1, 2001, any prescription drug used in
17 the treatment of Parkinson's disease, (7) beginning on January
18 1, 2001, any prescription drug used in the treatment of
19 glaucoma, (8) beginning on January 1, 2001, any prescription
20 drug used in the treatment of lung disease and smoking related
21 illnesses, (9) beginning on July 1, 2001, any prescription drug
22 used in the treatment of osteoporosis, and (10) beginning on
23 January 1, 2004, any prescription drug used in the treatment of
24 multiple sclerosis. The specific agents or products to be
25 included under such categories shall be listed in a handbook to
26 be prepared and distributed by the Department. The general
27 types of covered prescription drugs shall be indicated by rule.
28 (Source: P.A. 92-10, eff. 6-11-01; 92-790, eff. 8-6-02; 93-528,
29 eff. 1-1-04.)